Carbapenem-Resistant Enterobacteriaceae Infection Clinical Trial
Official title:
Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK Model
The goal of this study is to evaluate the efficacy and safety of ceftazidime-avibactam(CAZ-AVI) in the treatment of critically ill patients with carbapenem-resistant organisms(CRO) infections (including dialysis patients and extracorporeal membrane oxygenation(ECMO) patients).
This is a prospective observational multicentre study. The study is to obtain the real world data of the efficacy and safety of ceftazidime-avibactam(CAZ-AVI) in the treatment of critically ill patients with carbapenem-resistant organisms(CRO) infections (including dialysis patients and extracorporeal membrane oxygenation(ECMO) patients) by using therapeutic drug monitoring(TDM). A population-pharmacokinetic(PPK) model of CAZ-AV in these patients will be established in this study. The main question it aims to answer is the clinical success rate and microbiological success rate of CAZ-AVI based regimen in the treatment of critically ill patients with CRO infections. According to the clinical practice (symptoms, signs, imaging, culture and drug sensitivity, etc.), the doctor determines the combined regimen of CAZ-AVI, and the combined drugs are used routinely according to their instructions or clinical diagnosis and treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06051513 -
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
|
N/A | |
| Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A | |
| Completed |
NCT04146337 -
Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae
|
Phase 2/Phase 3 | |
| Completed |
NCT04167228 -
Impact of Ceftazidime / Avibactam Treatment vs Better Available Therapy on Mortality of Patients With Infections Caused by Carbapenem-resistant Enterobacteria
|
||
| Terminated |
NCT04876430 -
Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems
|
Phase 2/Phase 3 | |
| Enrolling by invitation |
NCT03924934 -
Community-associated Highly-Resistant Enterobacterales
|
||
| Recruiting |
NCT04583098 -
The Effect of Fecal Microbiota Transplantation on the Decolonization of Multidrug-resistant Organisms
|
||
| Recruiting |
NCT04535661 -
Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
|
||
| Withdrawn |
NCT04785924 -
Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
|
Phase 4 | |
| Terminated |
NCT05258851 -
Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections
|
Phase 3 | |
| Not yet recruiting |
NCT04746222 -
Oral Capsule Faecal Microbiota Transplantation for CPE Decolonization
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04014413 -
Safety and Efficacy of Fecal Microbiota Transplantation
|
N/A | |
| Recruiting |
NCT05871476 -
Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated Animals
|
N/A | |
| Recruiting |
NCT05850871 -
Drug Resistance Mechanism of Enterobacteriaceae and Its Strategies
|
N/A | |
| Terminated |
NCT05210387 -
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
|
N/A | |
| Not yet recruiting |
NCT05981430 -
Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae
|
N/A | |
| Recruiting |
NCT06258551 -
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
|
||
| Recruiting |
NCT05979545 -
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
|
Phase 4 | |
| Completed |
NCT04790565 -
Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae
|
Phase 2/Phase 3 |